4Q9Z

Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)

Summary for 4Q9Z

• Entry DOI: 10.2210/pdb4q9z/pdb
• Related: 4Q9S
• Descriptor: HUMAN PROTEIN KINASE C THETA, (1R)-9-(azetidin-3-ylamino)-1,8-dimethyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one, SODIUM ION, ... (4 entities in total)
• Functional Keywords: pkc theta kinase, kinase catalytic domain, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (human)
• Cellular location: Cytoplasm: Q04759
• Total number of polymer chains: 2
• Total formula weight: 79818.71

Authors

Argiriadi, M.A.,George, D.M. (deposition date: 2014-05-02, release date: 2014-07-02, Last modification date: 2015-01-21)

• Primary citation: George, D.M.,Breinlinger, E.C.,Friedman, M.,Zhang, Y.,Wang, J.,Argiriadi, M.,Bansal-Pakala, P.,Barth, M.,Duignan, D.B.,Honore, P.,Lang, Q.,Mittelstadt, S.,Potin, D.,Rundell, L.,Edmunds, J.J.; Discovery of Selective and Orally Bioavailable Protein Kinase C theta (PKC theta ) Inhibitors from a Fragment Hit.; J.Med.Chem., 58:222-236, 2015; PubMed: 25000588; DOI: 10.1021/jm500669m

Experimental method

X-RAY DIFFRACTION (2.6 Å)